Global CAR T-Cell Therapy for Multiple Myeloma Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application

SKU ID :QYR-14156917 | Published Date: 30-Apr-2019 | No. of pages: 93
Table of Contents CAR T-Cell Therapy for Multiple Myeloma Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025 1 Industry Overview of CAR T-Cell Therapy for Multiple Myeloma 1.1 CAR T-Cell Therapy for Multiple Myeloma Market Overview 1.1.1 CAR T-Cell Therapy for Multiple Myeloma Product Scope 1.1.2 Market Status and Outlook 1.2 Global CAR T-Cell Therapy for Multiple Myeloma Market Size and Analysis by Regions 1.2.1 North America 1.2.2 Europe 1.2.3 China 1.2.4 Rest of Asia Pacific 1.2.5 Central & South America 1.2.6 Middle East & Africa 1.3 CAR T-Cell Therapy for Multiple Myeloma Market by Type 1.3.1 Monotherapy 1.3.2 Combination Therapy 1.4 CAR T-Cell Therapy for Multiple Myeloma Market by End Users/Application 1.4.1 Multiple Myeloma 1.4.2 Refractory or Relapsed Multiple Myeloma 2 Global CAR T-Cell Therapy for Multiple Myeloma Competition Analysis by Players 2.1 CAR T-Cell Therapy for Multiple Myeloma Market Size (Value) by Players (2018 and 2019) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future 3 Company (Top Players) Profiles 3.1 Juno Therapeutics 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 CAR T-Cell Therapy for Multiple Myeloma Revenue (Value) (2014-2019) 3.1.5 Recent Developments 3.2 Kite Pharma 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 CAR T-Cell Therapy for Multiple Myeloma Revenue (Value) (2014-2019) 3.2.5 Recent Developments 3.3 Novartis 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 CAR T-Cell Therapy for Multiple Myeloma Revenue (Value) (2014-2019) 3.3.5 Recent Developments 3.4 Collectis 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 CAR T-Cell Therapy for Multiple Myeloma Revenue (Value) (2014-2019) 3.4.5 Recent Developments 4 Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Type and Application (2014-2019) 4.1 Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2014-2019) 4.2 Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2014-2019) 4.3 Potential Application of CAR T-Cell Therapy for Multiple Myeloma in Future 4.4 Top Consumer/End Users of CAR T-Cell Therapy for Multiple Myeloma 5 North America CAR T-Cell Therapy for Multiple Myeloma Development Status and Outlook 5.1 North America CAR T-Cell Therapy for Multiple Myeloma Market Size (2014-2019) 5.2 North America CAR T-Cell Therapy for Multiple Myeloma Market Size and Market Share by Players (2018 and 2019) 6 Europe CAR T-Cell Therapy for Multiple Myeloma Development Status and Outlook 6.1 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size (2014-2019) 6.2 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size and Market Share by Players (2018 and 2019) 7 China CAR T-Cell Therapy for Multiple Myeloma Development Status and Outlook 7.1 China CAR T-Cell Therapy for Multiple Myeloma Market Size (2014-2019) 7.2 China CAR T-Cell Therapy for Multiple Myeloma Market Size and Market Share by Players (2018 and 2019) 8 Rest of Asia Pacific CAR T-Cell Therapy for Multiple Myeloma Development Status and Outlook 8.1 Rest of Asia Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size (2014-2019) 8.2 Rest of Asia Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size and Market Share by Players (2018 and 2019) 9 Central & South America CAR T-Cell Therapy for Multiple Myeloma Development Status and Outlook 9.1 Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Size (2014-2019) 9.2 Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Size and Market Share by Players (2018 and 2019) 10 Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Development Status and Outlook 10.1 Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size (2014-2019) 10.2 Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size and Market Share by Players (2018 and 2019) 11 Market Forecast by Regions, Type and Application (2019-2025) 11.1 Global CAR T-Cell Therapy for Multiple Myeloma Market Size (Value) by Regions (2019-2025) 11.1.1 North America CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2019-2025) 11.1.2 Europe CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2019-2025) 11.1.3 China CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2019-2025) 11.1.4 Rest of Asia Pacific CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2019-2025) 11.1.5 Central & South America CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2019-2025) 11.1.6 Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Revenue and Growth Rate (2019-2025) 11.2 Global CAR T-Cell Therapy for Multiple Myeloma Market Size (Value) by Type (2019-2025) 11.3 Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2019-2025) 12 CAR T-Cell Therapy for Multiple Myeloma Market Dynamics 12.1 CAR T-Cell Therapy for Multiple Myeloma Market Opportunities 12.2 CAR T-Cell Therapy for Multiple Myeloma Challenge and Risk 12.2.1 Competition from Opponents 12.2.2 Downside Risks of Economy 12.3 CAR T-Cell Therapy for Multiple Myeloma Market Constraints and Threat 12.3.1 Threat from Substitute 12.3.2 Government Policy 12.3.3 Technology Risks 12.4 CAR T-Cell Therapy for Multiple Myeloma Market Driving Force 12.4.1 Growing Demand from Emerging Markets 12.4.2 Potential Application 13 Market Effect Factors Analysis 13.1 Technology Progress/Risk 13.1.1 Substitutes 13.1.2 Technology Progress in Related Industry 13.2 Consumer Needs Trend/Customer Preference 13.3 External Environmental Change 13.3.1 Economic Fluctuations 13.3.2 Other Risk Factors 14 Research Finding/Conclusion 15 Appendix Methodology Analyst Introduction Data Source
List of Tables and Figures Figure CAR T-Cell Therapy for Multiple Myeloma Product Scope Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) (2014-2019) Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Regions in 2018 Figure North America CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Europe CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure China CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Rest of Asia Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Type in 2018 Figure Monotherapy Market Size (Million USD) and Growth Rate (2014-2019) Figure Combination Therapy Market Size (Million USD) and Growth Rate (2014-2019) Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Application in 2018 Table Key Downstream Customer in Multiple Myeloma Figure CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) and Growth Rate in Multiple Myeloma (2014-2019) Table Key Downstream Customer in Refractory or Relapsed Multiple Myeloma Figure CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) and Growth Rate in Refractory or Relapsed Multiple Myeloma (2014-2019) Table CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) by Players (2018 and 2019) Figure CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Players in 2018 Figure CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Players in 2019 Table Juno Therapeutics Basic Information List Table CAR T-Cell Therapy for Multiple Myeloma Business Revenue (Million USD) of Juno Therapeutics (2014-2019) Figure Juno Therapeutics CAR T-Cell Therapy for Multiple Myeloma Business Revenue Market Share in 2018 Table Kite Pharma Basic Information List Table CAR T-Cell Therapy for Multiple Myeloma Business Revenue (Million USD) of Kite Pharma (2014-2019) Figure Kite Pharma CAR T-Cell Therapy for Multiple Myeloma Business Revenue Market Share in 2018 Table Novartis Basic Information List Table CAR T-Cell Therapy for Multiple Myeloma Business Revenue (Million USD) of Novartis (2014-2019) Figure Novartis CAR T-Cell Therapy for Multiple Myeloma Business Revenue Market Share in 2018 Table Collectis Basic Information List Table CAR T-Cell Therapy for Multiple Myeloma Business Revenue (Million USD) of Collectis (2014-2019) Figure Collectis CAR T-Cell Therapy for Multiple Myeloma Business Revenue Market Share in 2018 Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) by Type (2014-2019) Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Type in 2014 Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Type in 2015 Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Type in 2016 Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Type in 2017 Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Type in 2018 Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Type in 2019 Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) by Application (2014-2019) Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) by Application in 2014 Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) by Application in 2015 Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) by Application in 2015 Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) by Application in 2017 Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) by Application in 2018 Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) by Application in 2019 Table Top Consumer/End Users of CAR T-Cell Therapy for Multiple Myeloma Figure North America CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table North America CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) by Players (2014-2019) Figure North America CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Players in 2018 Figure North America CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Players in 2019 Figure Europe CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Europe CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) by Players (2014-2019) Figure Europe CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Players in 2018 Figure Europe CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Players in 2019 Figure China CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table China CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) by Players (2014-2019) Figure China CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Players in 2018 Figure China CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Players in 2019 Figure Rest of Asia Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Rest of Asia Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) by Players (2014-2019) Figure Rest of Asia Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Players in 2018 Figure Rest of Asia Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Players in 2019 Figure Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) by Players (2014-2019) Figure Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Players in 2018 Figure Central & South America CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Players in 2019 Figure Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) by Players (2014-2019) Figure Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Players in 2018 Figure Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Players in 2019 Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) by Regions (2019-2025) Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) by Regions (2019-2025) Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Regions in 2019 Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Regions in 2025 Figure North America CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) and Growth Rate (2019-2025) Figure Europe CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) and Growth Rate (2019-2025) Figure China CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) and Growth Rate (2019-2025) Figure Rest of Asia Pacific CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) and Growth Rate (2019-2025) Figure Central & South America CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) and Growth Rate (2019-2025) Figure Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Revenue (Million USD) and Growth Rate (2019-2025) Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) by Type (2019-2025) Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Type in 2019 Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Type in 2025 Table Global CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) by Application (2019-2025) Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) by Application in 2019 Figure Global CAR T-Cell Therapy for Multiple Myeloma Market Size (Million USD) by Application in 2025
Juno Therapeutics Kite Pharma Novartis Collectis
  • PRICE
  • $3350
    $6700
    $5025
    Buy Now

Our Clients